References
- FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
- BaeJSeoSSParkYSNatural history and epidemiology of HPV infection and cervical cancerGynecol Oncol20091151758019619893
- AerssensAClaeysPBeerensFPrediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasiaCytopathology2009201273518510550
- RattanalappaiboonDKleebkaowPChumworathayiBLaunratanakomSSantipongsupakornTFactors affecting compliance in the first year of postcolposcopy surveillance among women with a high incidence of cervical cancerInt J Gynaecol Obstet2014124216016324139474
- SandriMTLentatiPBeniniEComparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samplesJ Clin Microbiol20064462141214616757611
- ArbynMVerdoodtFSnijdersPJAccuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysisLancet Oncol201415217218324433684
- ArbynMHerbertASchenckUEuropean guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytologyCytopathology200718313313917573762
- VieraAJGarrettJMUnderstanding interobserver agreement: the kappa statisticFam Med200537536036315883903
- TaylorSWangCWrightTCDennyLKuhnLA comparison of human papillomavirus testing of clinician-collected and self-collected samples during follow-up after screen-and-treatInt J Cancer2011129487988620957631
- EinsteinMHSmithKMDavisTEClinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopyJ Clin Microbiol20145262089209524719440
- MoscickiABWiddiceLMaYComparison of natural histories of human papillomavirus detected by clinician- and self-samplingInt J Cancer201012781882189220104517
- JohnsonDCBhattaMPSmithJSAssessment of high-risk human papillomavirus infections using clinician- and self-collected cervical sampling methods in rural women from far western NepalPLoS One201496e10125524978811
- TingJMugoNKwatamporaJHigh-risk human papillomavirus messenger RNA testing in physician- and self-collected specimens for cervical lesion detection in high-risk women, KenyaSex Transm Dis201340758458923965776
- VergutsJBronselaerBDondersGPrediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisationBJOG2006113111303130716978225
- Omenge Orang’oOLiuTChristoffersen-DebAUse of visual inspection with acetic acid, Pap smear, or high-risk human papilloma-virus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different prioritiesAIDS201731223324028002084
- NelsonEJMaynardBRLouxTFatlaJGordonRArnoldLDThe acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysisSex Transm Infect2017931566128100761
- PetignatPFaltinDLBruchimITramerMRFrancoELCoutleeFAre self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysisGynecol Oncol2007105253053517335880
- KuncklerMSchumacherFKenfackBCervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approachCancer Med2017671752176128580596